Does PRAVASTATIN Cause Interstitial lung disease? 116 Reports in FDA Database
Lower Your Cholesterol — The Natural Way
The Oxidized Cholesterol Strategy: a science-backed plan for heart health.
According to the FDA Adverse Event Reporting System (FAERS), 116 reports of Interstitial lung disease have been filed in association with PRAVASTATIN (Pravastatin Sodium). This represents 1.4% of all adverse event reports for PRAVASTATIN.
116
Reports of Interstitial lung disease with PRAVASTATIN
1.4%
of all PRAVASTATIN reports
12
Deaths
82
Hospitalizations
How Dangerous Is Interstitial lung disease From PRAVASTATIN?
Of the 116 reports, 12 (10.3%) resulted in death, 82 (70.7%) required hospitalization, and 12 (10.3%) were considered life-threatening.
Is Interstitial lung disease Listed in the Official Label?
Yes, Interstitial lung disease is listed as a known adverse reaction in the official FDA drug label for PRAVASTATIN.
What Other Side Effects Does PRAVASTATIN Cause?
Myalgia (1,290)
Arthralgia (570)
Dyspnoea (514)
Fatigue (500)
Drug hypersensitivity (493)
Diarrhoea (478)
Headache (448)
Pruritus (432)
Nausea (420)
Dizziness (413)
What Other Drugs Cause Interstitial lung disease?
METHOTREXATE (3,049)
RITUXIMAB (2,458)
PEMBROLIZUMAB (2,113)
PREDNISONE (1,850)
CYCLOPHOSPHAMIDE (1,725)
NIVOLUMAB (1,538)
AMIODARONE (1,421)
DOXORUBICIN (1,352)
ETANERCEPT (1,267)
ADALIMUMAB (1,250)
Which PRAVASTATIN Alternatives Have Lower Interstitial lung disease Risk?
PRAVASTATIN vs PRAVASTATIN\PRAVASTATIN
PRAVASTATIN vs PRAZAXA
PRAVASTATIN vs PRAZEPAM
PRAVASTATIN vs PRAZIQUANTEL
PRAVASTATIN vs PRAZOSIN